Susan G. Komen® Unveils $26 Million Investment in Research Funding Focused on Metastatic Breast Cancer and New Treatments
Similar Posts
OncoHost Launches PROphet NSCLC Cancer Test in the United States
Predictive blood test guides first-line treatment decisions for advanced unresectable non-small lung cancer patients OncoHost, a precision diagnostics company…
RxRevu and FDB Partner to Accelerate Delivery of Real-Time Prescription Benefit Data to the Point of Care
RxRevu and FDB team up to accelerate delivery of Rx benefit data at the POC RxRevu, the leading provider…
Medical Home Network, NeueHealth Help FQHCs Achieve $10.1M+ Savings
Medical Home Network (MHN) provider partners participating in NeueHealth Premier ACO achieved $10.1 million in gross savings and…
Healthcare Leaders Say Affordability Crisis Requires Shared Accountability Across the Industry
A new Vitalic Health survey finds broad concern over the financial sustainability of U.S. healthcare, with most respondents warning…
New Webinar from GE Healthcare Explores Innovations in Optimized Tools for High-confidence Gene Engineering
The webinar, hosted by LabRoots on October 27, 2016, will delve into the advancements being made in genome engineering…
